Entity: Drug Enforcement Administration

Records Regarding Communications with DEA on the Opioid Crisis

August 28, 2019
Records from the Department of Justice's Drug Enforcement Administration in response to American Oversight's request for communications between the Drug Enforcement Administration and the U.S. Department of Health and Human Services regarding the opioid crisis.

Watchdog Demands Records on Rudy Giuliani’s Past Consulting for OxyContin Manufacturer

August 24, 2018
American Oversight today demanded the release of records to uncover the role that Rudy Giuliani may have played in quashing federal investigations into Purdue Pharma, the manufacturer of the powerful prescription opioid OxyContin. In the early 2000s, Purdue worked with Giuliani’s consulting firm while Giuliani served as a consultant to the Justice Department (DOJ) on opioid issues and fundraised for a museum honoring the Drug Enforcement Administration

FOIA to DEA Seeking Communications With Giuliani Regarding Opioids

August 24, 2018
FOIA to DEA seeking communications between senior DEA appointees and Rudy Giuliani or Purdue Pharma between 2002-2008.

FOIA to DOJ Seeking Communications with DEA Regarding the Opioid Crisis

February 16, 2018
FOIA to DOJ seeking communications between the DEA and the U.S. Department of Health and Human Services regarding the authority to allow for expanded access to remote prescribing of medicines for substance abuse treatment by telemedicine granted by the Trump administration’s October 26, 2017 declaration of a public health emergency resulting from the opioid crisis.